Substance use issues affecting specific groups, considering their unique risk factors and needs.
Populations
Consideration of vaping products as an alternative to adult smoking: a narrative review
Tobacco harm reduction is a public health strategy aimed at lessening the health impact of cigarette smoking. This approach involves using non-combustible alternatives to cigarettes, such as electronic cigarettes (e-cigarettes), which...
Challenges in substance use treatment as perceived by professionals and Arabic-speaking refugees in Germany
Background This study explores substance use (SU) and substance use disorders (SUDs) among Arabic-speaking refugees in Germany. The research investigates the challenges and experiences related to SU treatment from the perspectives of both...
Engagement in the Black Community Summit
The fourth annual Engagement in the Black Community: A Virtual NAADAC Summit will take place on February 8-9, 2024!
“Safer Drug Supply” Measures in Canada to Reduce the Drug Overdose Fatality Toll: Clarifying Concepts, Practices and Evidence Within a Public Health Intervention Framework
In North America, there's a serious problem with drug overdose deaths, mainly due to users encountering very strong and dangerous illegal opioids like fentanyl. Although various efforts have been made in Canada to address this issue, the...
Synthetic Opioids: Navigating a Changing Landscape in the Treatment of Opioid Use Disorder
This 35-minute module focuses on how primary care providers can navigate the changing landscape of opioid use disorder in relation to synthetic opioids.
Pediatric Cannabis Poisoning Stakeholder Toolkit Cannabis
Recent research has revealed an increase in child hospitalisations resulting from accidental cannabis poisoning in various regions of Canada. Toddlers find cannabis edibles enticing due to their resemblance to common treats like candies...
Gender differences in physical morbidity in opioid agonist treatment patients: population-based cohort studies from the Czech Republic and Norway
Background: Physical health problems are common in people receiving opioid agonist treatment (OAT). A study was conducted on these health issues in OAT patients in the Czech Republic and Norway from 2010 to 2019, with a focus on gender...
Regional, circuit and network heterogeneity of brain abnormalities in psychiatric disorders
Abstract The substantial individual heterogeneity that characterizes people with mental illness is often ignored by classical case–control research, which relies on group mean comparisons. Here we present a comprehensive, multiscale...
Contemporary Drug Problems Conference
Building on CDP’s previous conferences, which have opened up questions of how drugs are problematised; how the complexity of drug use can be attended to; how drug use might be understood as an event, assemblage or phenomenon; how drugs and their effects are constituted in various forms of practice and interactions/intra-actions, and how we might rethink change.
Children and parents affected by drug use: An overview of programmes and actions for comprehensive and non-stigmatising services and care
After exploring the views of women and children, respectively, in Volumes II and III of this series, the fourth volume offers a perspective of how to develop more comprehensive, child-centred approaches in drug policies in general and in...
